Arsenic Trioxide in Recurrent and Metastatic Ovarian Cancer and Endometrial Cancer With P53 Mutation
- Status
- UNKNOWN
- Phase
- NA
Clinical Trials Related to Ovarian Cancer
Related studies linked through entity extraction aliases.
Transvaginal Ultrasonography as a Screening Method for Ovarian Cancer
- Status
- RECRUITING
- Phase
- NA
A Randomized Prospective Trail of HIPEC in Recurrent Ovarian Cancer Patients With HRR Mutation
- Status
- UNKNOWN
- Phase
- PHASE3
STOP OVarian CAncer; Implementation of the Opportunistic Salpingectomy in the Netherlands
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- N/A
Safety and Preliminary Efficacy of SNK01 in Combination With Trastuzumab or Cetuximab in Subjects With Advanced HER2 or EGFR Cancers
- Status
- WITHDRAWN
- Phase
- PHASE1/PHASE2
Targeted Radiation Therapy for Ovarian Cancer: Intraperitoneal Treatment With 211-astatine-MX35 F(ab')2
- Status
- COMPLETED
- Phase
- EARLY_PHASE1
Exemestane in Hormone Receptor Positive High Grade Ovarian Cancer
- Status
- TERMINATED
- Phase
- PHASE3
Feasibility and Evaluation of a Self-care App to Enhance Purposeful Living
- Status
- COMPLETED
- Phase
- NA
Using Advanced Imaging Studies to Develop a Profile of High-grade Serous Ovarian Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- NA
Connected Prehabilitation Program During Neo Adjuvant Chemotherapy
- Status
- NOT_YET_RECRUITING
- Phase
- NA
A Study of the PD-L1xCD27 Bispecific Antibody CDX-527 in Patients With Advanced Malignancies
- Status
- COMPLETED
- Phase
- PHASE1
Dose Escalation Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of QBS10072S
- Status
- COMPLETED
- Phase
- PHASE1
Roll Over StudY for Patients Who Have Completed a Previous Oncology Study With Olaparib
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
Olaparib Monotherapy and Olaparib + Pembrolizumab Combination Therapy for Ovarian Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Factors Affecting the Prognosis of Early Ovarian Cancer
- Status
- UNKNOWN
- Phase
- N/A
A Safety and Tolerability Study of NC410 in Subjects With Advanced or Metastatic Solid Tumors
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Phase 1 Study of SL-172154 (SIRPα-Fc-CD40L) in Subjects With Ovarian Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Minimally Invasive Robotic Surgery, Role in Optimal Debulking Ovarian Cancer, Recovery & Survival
- Status
- UNKNOWN
- Phase
- N/A
Effect of Hemp-CBD on Patients With CIPN
- Status
- UNKNOWN
- Phase
- PHASE2
First-in-Human Study of XMT-1592 in Patients With Ovarian Cancer and NSCLC Likely to Express NaPi2b
- Status
- TERMINATED
- Phase
- PHASE1